Tracey O’Brien: The Future of Precision Cancer Care
Tracey O'Brien/LinkedIn

Tracey O’Brien: The Future of Precision Cancer Care

Tracey O’Brien, Chief Cancer Officer and CEO of Cancer Institute NSW, shared UNSW Medicine & Health’s post on LinkedIn, adding:

“I’m excited to take part in this moderated discussion on the future of precision cancer care featuring Samantha Oakes, Paul Steven Conyngham and Fatemeh Vafaee.

My fellow panellists come from diverse backgrounds in science, data and AI so I am sure I will learn a great deal and the brilliant Julie McCrossin AM will cover significant ground as moderator!”

Quoting UNSW Medicine & Health’s post:

“Cancer is changing. But so is the way we find and fight it.

AI, genomics and precision medicine are transforming how we understand and manage cancer, but how do we ensure these advances benefit everyone?

Join us for Cancer Reimagined: The Future of Precision Care, a panel discussion exploring how medical advances are reshaping treatment, and what it takes to turn scientific breakthroughs into better, more equitable health outcomes for all.”

Register to attend: Cancer Reimagined: The Future of Precision Care

Hear from Professor Tracey O’Brien, AM, Samantha Oakes, Paul Steven Conyngham and Fatemeh Vafaee, in a panel moderated by Julie McCrossin AM.

This event is presented by UNSW Medicine & Health and UNSW Science.

Tracey O'Brien

Other articles features Tracey O’Brien on OncoDaily.